|2.||Gustatory Sweating (Frey's Syndrome)
|4.||Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome)
|5.||Raynaud Disease (Raynaud's Disease)
|1.||Wolosker, Nelson: 41 articles (09/2015 - 09/2003)|
|2.||Kauffman, Paulo: 39 articles (09/2015 - 09/2003)|
|3.||Puech-Leão, Pedro: 25 articles (09/2015 - 08/2005)|
|4.||de Campos, José Ribas Milanez: 16 articles (01/2014 - 09/2003)|
|5.||Krutman, Mariana: 12 articles (09/2015 - 10/2012)|
|6.||Yazbek, Guilherme: 12 articles (05/2013 - 08/2005)|
|7.||Glaser, Dee Anna: 10 articles (09/2015 - 11/2004)|
|8.||Sand, Michael: 10 articles (05/2012 - 05/2006)|
|9.||Altmeyer, Peter: 10 articles (05/2012 - 03/2006)|
|10.||Jatene, Fábio Biscegli: 10 articles (01/2012 - 09/2003)|
|1.||Botulinum Toxins (Botulinum Toxin)IBA
02/01/2012 - "In conclusion, we consider that low doses of botulinum toxin A is a well tolerated, safe and very effective treatment for primary frontal hyperhidrosis and it should be offered as an alternative to patients who suffer from this disorder."
01/01/2007 - "Botulinum toxin is a safe and effective treatment for idiopatic focal axillary and palmar hyperhidrosis, but very few data are reported in the literature on its effect on plantar idiopatic hyperhidrosis. "
10/01/2000 - "Botulinum toxin A has been shown to be a very effective treatment for focal hyperhidrosis of the axillae and palms. "
01/01/2003 - "Botulinum toxin A has emerged as a treatment for hyperhidrosis over the past 5-6 years with studies showing good results. "
03/01/2008 - "Few recent clinical studies have suggested that botulinum toxin is effective in the treatment of plantar hyperhidrosis. "
|2.||Type A Botulinum Toxins (Botulinum A Toxin)FDA Link
01/01/2009 - "Botulinum Toxin type A (BTX-A) has revolutionized the treatment of focal hyperhidrosis (HH) in recent years and has dramatically reduced the invasive surgical techniques that have been performed in the past to control severe focal HH unresponsive to topical therapies. "
08/01/2002 - "Botulinum toxin type A (BTX-A) has been shown to be highly effective in reducing palmar hyperhidrosis. "
12/01/2004 - "Clinical trials investigating botulinum toxin type A use in axillary and palmar hyperhidrosis show significant benefits with few side-effects reported, with a favourable impact also being seen on patient quality of life. "
01/01/2008 - "As a result, there is a strong evidence to support the efficacy of botulinum toxin type A in axillary (Level A evidence) and palmar (Level B evidence) hyperhidrosis."
09/15/2001 - "Botulinum toxin type A is a safe and effective treatment for primary axillary hyperhidrosis and produces high levels of patient satisfaction."
|3.||oxybutynin (Tavor)FDA LinkGeneric
09/01/2014 - "Oxybutynin is effective for treating bothersome hyperhidrosis, even at atypical locations and most patients cope well with the side effects."
01/01/2008 - "Oxybutynin has been proven to be effective in patients with generalized hyperhidrosis. "
12/01/2014 - "Among patients with good initial responses to oxybutynin, more than 90 % experienced moderate or great improvement in their palmar sweating, as well as in their hyperhidrosis in other sites, after 6 months. "
09/01/2014 - "Oxybutynin has provided good results and is an alternative for treating hyperhidrosis at common sites. "
05/01/2013 - "Treatment of plantar hyperhidrosis with oxybutynin presents good results and improves quality of life. "
|4.||onabotulinumtoxinA (Botox)FDA Link
09/01/2015 - "A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis."
08/01/1998 - "The current study was undertaken to demonstrate the utility of using Botox in the treatment of axillary hyperhidrosis. "
09/01/2015 - "To evaluate the efficacy and safety of onabotulinumtoxinA in adolescents with primary axillary hyperhidrosis. "
09/01/2013 - "OnabotulinumtoxinA therapy for compensatory hyperhidrosis."
05/01/2013 - "Onabotulinum toxin A injection is an effective third-line treatment for primary focal hyperhidrosis. "
|5.||Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
11/01/2004 - "We conclude that glycopyrrolate iontophoresis is more effective than tap water iontophoresis in the treatment of palmoplantar hyperhidrosis and that glycopyrrolate iontophoresis has both local and systemic effects on perspiration."
01/01/2013 - "Glycopyrrolate is an effective medication in the treatment of compensatory hyperhidrosis that, can alleviate anxiety and improve patients' quality of life."
09/01/2012 - "Iontophoresis using glycopyrronium bromide is an effective and well-tolerated treatment for primary palmar hyperhidrosis. "
07/01/2002 - "We conclude that topical glycopyrrolate is effective in treating craniofacial hyperhidrosis and is associated with few adverse effects."
01/01/2014 - "Our retrospective analysis suggests that oral glycopyrrolate is safe and effective in children with hyperhidrosis. "
01/01/2015 - "Fields of anhidrotic effects of abobotulinumtoxinA in patients with compensatory hyperhidrosis."
08/01/2014 - "Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: a randomized, controlled trial."
08/01/2009 - "We report on a case of severe atrophy of the intrinsic muscles of the hands in a patient treated with intra-palmar BTX-A (Dysport, Speywood, UK) injections for hyperhidrosis. "
05/01/2003 - "This French study confirms the efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis with relatively low doses (100 U of Dysport per armpit and 250 U per palm). "
01/01/2013 - "Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis."
03/01/1984 - "Seven patients with hyperhidrosis of the palms or soles resistant to topical application of aluminum chloride solution were treated successfully with tap water iontophoresis. "
01/01/2011 - "The purpose of this study is to investigate the effect of 30 min iontophoretic application of low concentration (1%) aluminum chloride solution in patients with palmar hyperhidrosis. "
03/01/2014 - "A 12-week duration treatment with topical aluminum chloride was evaluated in patients with persisting hyperhidrosis. "
09/01/2013 - "Ultrasonography detects symmetrical lividities of the soles of the feet: a non-hyperhidrosis case treated with AlCl3 solution."
06/01/2012 - "In the treatment of focal hyperhidrosis, the use of aluminum chloride solutions represents the first choice. "
01/01/1998 - "Despite a high incidence of compensatory hyperhidrosis, TES improved both the symptoms and overall quality of life in patients with upper limb hyperhidrosis."
01/01/1999 - "TES is thus a safe and effective method for treating palmar and axillary hyperhidrosis in children and adolescents."
12/01/2008 - "To study the sympathetically mediated effects of transthoracic endoscopic sympathicotomy (TES) in the treatment of severe primary palmar hyperhidrosis. "
01/01/2002 - "Seventy patients with palmar hyperhidrosis undergoing bilateral TES (140 sides) via the anterior subaxillary approach were included in this study. "
12/01/2008 - "Besides the high success rate of good clinical effect of TES on palmar hyperhidrosis, major effects on local blood flow and temperature are elicited by TES. "
03/01/2005 - "Neurobloc is an effective treatment for axillary hyperhidrosis."
03/01/2005 - "Myobloc proved to be efficacious for the treatment of palmar hyperhidrosis. "
07/01/2014 - "Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study."
05/01/2005 - "Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis."
03/01/2005 - "We evaluated the safety and efficacy of Myobloc in the treatment of bilateral palmar hyperhidrosis. "
|10.||batrachotoxinin A 20-alpha-benzoateIBA
10/01/2014 - "In this prospective, uncontrolled study Btx B seems to be both a safe and effective treatment in craniofacial hyperhidrosis improving quality of life and reducing extreme sweating."
03/01/2005 - "There are sparse data, however, in the literature evaluating the safety and efficacy of BTX-B for the treatment of palmar hyperhidrosis. "
10/01/2014 - "To evaluate the safety and clinical effect of Btx B in craniofacial hyperhidrosis. "
01/01/2004 - "This chapter will review what is currently known about BTX-B and its current use in regards to the treatment of hyperhidrosis."
01/01/2004 - "This past year researchers have been investigating the efficacy as well as defining the dosing and application regiments of BTX-B in the treatment of hyperhidrosis. "
08/01/2014 - "Endoscopic thoracic sympathectomy has been accepted as the most effective treatment for palmar hyperhidrosis (PH). "
06/01/2013 - "Video-assisted thoracoscopic sympathectomy is currently the best treatment for palmar and axillary hyperhidrosis. "
01/01/2004 - "Endoscopic thoracic (T2-3 or T3-4) sympathectomy (ETS) is a highly effective treatment for palmar hyperhidrosis. "
07/03/1999 - "Primary hyperhidrosis showed the best results after thoracoscopic sympathectomy. "
01/01/1999 - "Thoracoscopic sympathectomy is considered the most effective treatment for hyperhidrosis palmaris. "
10/01/2015 - "However it has to be administered by a skilled clinician and involves around 20 injections to treat axillary hyperhidrosis. "
02/01/2014 - "Injections with BTX are the most effective nonoperative therapy for hyperhidrosis. "
01/01/2009 - "This article reviews the epidemiology, diagnosis, and management of primary focal hyperhidrosis, with an emphasis on recent research evidence supporting the use of BTX-A injections for this indication."
08/01/2007 - "The objective was to evaluate whether or not injections with BTX-A are an effective therapy option for the treatment of focal hyperhidrosis of the anal fold. "
01/01/2007 - "A total of 20 patients with forehead hyperhidrosis received four injections of BoNTA in their forehead (one medial and lateral injection of one formulation randomly assigned to one forehead side, one medial and lateral injection of the other formulation to the other forehead side). "
11/01/2002 - "Subcorial curettage is an effective treatment of axillary hyperhidrosis for patients with baseline sweat rates greater than 25 mg/min."
05/01/2001 - "The purpose of this study was to compare the efficacy of subcutaneous curettage vs. injection of BT-A in axillary hyperhidrosis. "
11/01/2002 - "Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis."
01/01/2005 - "The aim of this study was to establish the safety, efficacy, and durability of subdermal (subcorial) suction sweat gland curettage in the treatment of axillary hyperhidrosis. "
05/01/2001 - "A total of 113 patients (36.3% males, 63.7% females) suffering from genuine axillary hyperhidrosis were treated by either subcutaneous curettage (n = 90) or local injection of BT-A (n = 23). "
01/01/2001 - "Consequently, a number of clinical studies demonstrated good efficacy of intradermal injections of botulinumtoxin in patients with focal hyperhidrosis. "
01/01/2015 - "Following an observed reduction in the peristalsic shortening of a stoma after intradermal injection of BoNT-A for hyperhidrosis, we conducted a prospective case series of 10 patients with pouch adhesive failures attributed to spasmodic shortening of the stoma. "
09/01/2014 - "Peristomal hyperhidrosis can be controlled with BTX-A intradermal injections, improving patient pouch adherence and alleviating moisture-associated skin damage."
10/01/2013 - "In this open, controlled, non-randomized, intra-individual clinical trial, 50 patients with severe palmar hyperhidrosis received in the same session intradermal injections of BoNT/A through a new injection technique (NA/BoNT/A) based on the use of a specific adapter for needles (PCT/IT2011/000299) in one hand, and BoNT/A injection following the anaesthetic block of the wrist (WB/BoNT/A) in the other. "
01/28/2013 - "Systemic toxicity concerns require BT to be administered by local injection, which in the case of hyperhidrosis means multiple painful intradermal injections by a skilled clinician at 6-monthly intervals. "
10/01/1996 - "There was significant reduction in the severity of hyperhidrosis on the iontophoresis treated palm after treatment. "
01/01/2014 - "In the younger age group, 75% of patients referred a "partial" or "great" improvement in level of hyperhidrosis after treatment. "
10/01/2012 - "A total of 70% of patients in both groups presented partial or great improvement in the level of hyperhidrosis after treatment. "
09/01/2012 - "We studied the evolution of PH, negative effect of hyperhidrosis on the QOL before the treatment, and improvement in QOL after treatment. "
08/01/2015 - "Hyperhidrosis Disease Severity Scale was assessed before and after treatment up to 20 weeks. "